Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.94 | N/A |
| PEG Ratio (TTM) | -1.73 | N/A |
| P/S Ratio (TTM) | 2.36 | N/A |
| P/B Ratio (TTM) | 1.08 | N/A |
| P/FCF Ratio (TTM) | 12.68 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.73 | N/A |
| Price to 5YR AVG FCF Ratio | 14.32 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.77% | N/A |
| ROE (TTM) | 6.86% | N/A |
| Net Profit Margin (TTM) | 14.80% | N/A |
| ROIC 5YR AVG | 13.13% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -8.11% | 32.90% | 13.48% |
| Revenue | 3.03% | 7.94% | 9.64% |
| Net Income | -8.48% | 30.37% | 17.21% |
| Cash Flow | 23.02% | 2.85% | 9.87% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.21 | N/A |
| Quick Ratio (TTM) | 0.21 | N/A |
| D/E Ratio (TTM) | 0.56 | N/A |
| Interest Coverage (TTM) | 0.61 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 0.79 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.52% | N/A |